Severe secondary hyperparathyroidism in a chronic kidney disease patient treated with Radiofrequency ablation: One case report
End-stage renal disease (ESRD) is a global health problem with a high incidence (1) and a steadily increasing prevalence (2). Secondary hyperparathyroidism (SHPT) is a common and serious complication of chronic renal failure (CRF) in dialysis patients (3). It is mainly manifested as parathyroid hype...
Main Authors: | Gulimire Muhetaer, Guangyi Liu, Ling Zhang, Hong Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.876692/full |
Similar Items
-
Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism with or without previous parathyroidectomy: a retrospective study
by: Chi-Cheng Chen, et al.
Published: (2022-12-01) -
Value of contrast-enhanced ultrasonography in radiofrequency ablation of secondary hyperparathyroidism
by: Xiachuan Qin, et al.
Published: (2021-01-01) -
US-guided percutaneous radiofrequency ablation of secondary hyperparathyroidism as a bridge to renal transplantation
by: Wenwen Yue, et al.
Published: (2023-12-01) -
Laboratory criteria for the persistence of secondary hyperparathyroidism in patients with chronic kidney disease
by: M. Urina, et al.
Published: (2020-11-01) -
Radiofrequency Ablation of Parathyroid Adenoma: A Novel Treatment Option for Primary Hyperparathyroidism
by: Iram Hussain, MD, et al.
Published: (2021-05-01)